Prophylactic Anticoagulation
Showing 1 - 25 of 2,832
Anticoagulants; Increased Trial (catheter induced thromboprophylaxis)
Not yet recruiting
- Anticoagulants; Increased
- catheter induced thromboprophylaxis
- (no location specified)
Jan 21, 2023
Severe COVID-19 Pneumonia Trial in Créteil (Tinzaparin, Low dose prophylactic anticoagulation, Tinzaparin, High dose
Completed
- Severe COVID-19 Pneumonia
- Tinzaparin, Low dose prophylactic anticoagulation
- +2 more
-
Créteil, FranceHenri Mondor Hospital
Sep 5, 2022
Covid19 Trial in Tehran (intermediate dose Enoxaparin/ unfractionated heparin, standard prophylactic dose Enoxaparin/
Completed
- Covid19
- intermediate dose Enoxaparin/ unfractionated heparin
- +3 more
-
Tehran, Iran, Islamic Republic ofMasih Daneshvari Hospital
Aug 14, 2021
Covid19 Trial in Worldwide (theraputic heparin, prophylactic heparin, P2Y12)
Terminated
- COVID-19
- Enoxaparin Higher Dose
- Lower-dose prophylactic anticoagulation
-
New York, New YorkNYU Langone Health
Oct 5, 2020
Prophylactic Versus Therapeutic Dose Anticoagulation In COVID-19
Completed
- Covid19
-
Royal Oak, MichiganBeaumont Health System (BHS)
Apr 1, 2021
Sars-CoV2, COVID Trial in United States (Enoxaparin, Prophylactic/Intermediate Dose Enoxaparin)
Completed
- Sars-CoV2
- COVID
- Enoxaparin
- Prophylactic/Intermediate Dose Enoxaparin
-
Newark, New Jersey
- +5 more
Nov 17, 2021
Covid19 Trial in Banha (Ivermectin, Hydroxychloroquine, personal protective Measures)
Completed
- Covid19
- Ivermectin
- +2 more
-
Banhā, Qaluopia, EgyptBenha Faculty of Medicine, Benha University
Dec 11, 2020
Venous Thrombosis Due to Central Venous Access Device (Disorder), Prophylactic Anticoagulation, Patients With Tumor Trial in
Unknown status
- Venous Thrombosis Due to Central Venous Access Device (Disorder)
- +2 more
- Rivaroxaban 10mg
- +2 more
-
Dongyang, Zhejiang, China
- +27 more
Jun 26, 2020
COVID 19 Associated Coagulopathy Trial in Iowa City, La Crosse (Intermediate dose thromboprophylaxis, Standard of Care
Recruiting
- COVID 19 Associated Coagulopathy
- Intermediate dose thromboprophylaxis
- Standard of Care thromboprophylaxis
-
Iowa City, Iowa
- +1 more
Jun 18, 2020
Venous Thromboembolism Trial in Toronto (Prophylactic low molecular weight heparin, Low molecular weight heparin and low-dose
Recruiting
- Venous Thromboembolism
- Prophylactic low molecular weight heparin
- Low molecular weight heparin and low-dose aspirin
-
Toronto, Ontario, CanadaMount Sinai Hospital
Jan 18, 2023
Covid19 Trial in Germany (Anticoagulation Agents (Edoxaban and/or high dose LMWH), Low dose Low molecular weight heparin or
Recruiting
- Covid19
- Anticoagulation Agents (Edoxaban and/or high dose LMWH)
- Low dose Low molecular weight heparin or Placebo
-
Aachen, Germany
- +9 more
May 16, 2022
Prolonged Anticoagulation, Venous Thromboembolic Disease, Autoimmune Hemolytic Anemia Trial in Dijon (treatment "intervention",
Recruiting
- Prolonged Anticoagulation
- +2 more
- treatment "intervention"
- +2 more
-
Dijon, FranceChu Dijon Bourgogne
Jul 4, 2022
Coronavirus Infection Trial in Brazil (Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed,
Completed
- Coronavirus Infection
- Group 1: Rivaroxaban 20mg/d followed by enoxaparin/unfractionated heparin when needed
- Group 2: control group with enoxaparin 40mg/d
-
Salvador, Bahia, Brazil
- +35 more
Jun 8, 2021
Reduce Postoperative Atrial Fibrillation After Cardiac Surgery
Active, not recruiting
- Atrial Fibrillation New Onset
- Prophylactic amiodarone and posterior pericardiotomy
-
Boston, MassachusettsMassachusetts General Hospital
Mar 20, 2023
Thrombophilia Trial in Boston (No intervention)
Active, not recruiting
- Thrombophilia
- No intervention
-
Boston, MassachusettsBrigham and Women's Hospital
Jan 11, 2023
COVID-19 Trial in Germany (Rivaroxaban, Standard Of Care (SOC))
Terminated
- COVID-19
- Rivaroxaban
- Standard Of Care (SOC)
-
Freiburg, Baden-Württemberg, Germany
- +23 more
Dec 23, 2021
Acute Hypoxemic Respiratory Failure, Anticoagulant-induced Bleeding, Thromboembolism Trial in Nashville (Low intensity
Recruiting
- Acute Hypoxemic Respiratory Failure
- +2 more
- Low intensity anticoagulation
- Moderate Intensity Anticoagulation
-
Nashville, TennesseeVanderbilt University Medical Center
May 15, 2022
Peripartum Cardiomyopathy, Postpartum Trial in Pittsburgh (Bromocriptine, Placebo, Guideline Directed Medical Therapy for Heart
Recruiting
- Peripartum Cardiomyopathy, Postpartum
- Bromocriptine
- +4 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh Medical Center
Jun 9, 2022
Blood Clots and Bleeding in Hematological Malignancies, HAT
Recruiting
- Acute Leukemia
- +7 more
- Biospecimen Collection
- Electronic Health Record Review
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jun 17, 2022